Article Text

Download PDFPDF
COVID-19 vaccination and immunomodulatory or immunosuppressive drugs: indications and contraindications
  1. Yashdeep Singh Pathania
  1. Department of Dermatology, Venereology and Leprology, Derma Care, Kangra, Himachal Pradesh, India
  1. Correspondence to Dr Yashdeep Singh Pathania, Dermatology, Venereology and Leprology, Derma Care, Kangra, Himachal Pradesh, India; yashdeepsinghpathania{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor,

The COVID-19 pandemic has taken millions of human lives and is still accelerating to severely affect globally. With the advent of SARS-CoV-2 vaccines viz, mRNA, recombinant adenovirus vector and whole virion inactivated vero cell, which are inactivated vaccines having emergency use authorisation granted by the US Food and Drug Administration on 11 December 2020, led to a ray of hope in the COVID-19 pandemic. Immunotherapy has shown an importance in treating severe COVID-19, but the development of vaccine has been considered to be crucial for protecting the uninfected. The Australasian medical dermatology group strongly recommended COVID-19 vaccination in patients on immunomodulatory or biological agents as no specific contraindication or identifiable safety issues have been identified until.1 According to public health England’s immunisation against infectious disease, patients on immunosuppressed medications are …

View Full Text


  • Contributors The author (YSP) prepared and finalised the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.